GLYTHERA
Live / Registered — International registration cancelled — extension of protection cancelled (as of 09 Dec 2024)
What this means for you
Registered since 22 Mar 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79160490
- Registration number
- 4920063
- Mark type
- Stylized text
- Filed
- 08 Dec 2014
- Published for opposition
- 05 Jan 2016
- Registered
- 22 Mar 2016
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 001 — Chemicals: Chemicals used in industry and science; chemical products for use in industry and science, namely, vinyl pyridine-based linkers, vinyl pyridine derivatives, and difluorosialic acid; reagents for use in scientific apparatus for chemical or biological analysis; reagents for medical research; in-vivo diagnostic reagents; chemical preparations for scientific and industrial processes, namely, vinyl pyridine-based linkers, vinyl pyridine derivatives, and difluorosialic acid; enzymes for scientific and industrial purposes; biological cell cultures for use in scientific research; all the aforementioned goods excluding goods in the field of gene therapy
- Class 016 — Paper goods and printed matter: Paper; cardboard; printed matter, namely, paper signs, books, manuals, business cards, newsletters, informational cards, posters, brochures, letters, data packages, certificates in the field of biotherapeutics; bookbinding material; photographs; stationery; Printed instructional, educational, and teaching materials in the field of medicine; publications, namely, books, hand-outs, workbooks, posters, research articles in the fields of science, medicine and biotherapeutics; publications for the medical profession, namely, magazines, newsletters, research articles in the field of medicine
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research, design, analysis and testing in the field of biotherapeutics for treating cancer; industrial analysis and research services, namely, synthetic chemistry, bioconjugation, and scientific analysis of antibody-drug conjugates and biotherapeutics; biological research; biotechnology testing services, namely, synthetic chemistry, recombinant protein production, bioconjugation, testing, analysis, and evaluation of antibody-drug conjugates and biotherapeutics to assure compliance with industry standards; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; conducting clinical trials for others; design of clinical trials for others in the field of vaccines, biotherapeutics and antibody-drug conjugates; scientific research for medical purposes; scientific research for medical purposes in the area of cancerous diseases; information, advisory and consultancy services relating to the aforesaid; all the aforementioned services excluding services in the field of gene therapy
Owner
- IKSUDA THERAPEUTICS LIMITED, GB
- Glythera Limited, Newcastle upon Tyne NE1 7RU, GB
- Glythera Limited, Newcastle upon Tyne NE1 7RU, GB
Prosecution history
- 27 Jun 2025 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
- 27 Jun 2025 — DEATH OF INTERNATIONAL REGISTRATION
- 29 Nov 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 31 Jul 2023 — TOTAL INVALIDATION PROCESSED BY THE IB
- 11 Jul 2023 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 11 Jul 2023 — INVALIDATION PROCESSED
- 07 Jun 2023 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 07 Oct 2022 — CANCELLED SECTION 71
- 22 Mar 2021 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 12 Feb 2021 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 22 Jan 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 01 Feb 2019 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 26 Aug 2016 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 14 Jul 2016 — NEW REPRESENTATIVE AT IB RECEIVED
- 24 Jun 2016 — FINAL DISPOSITION NOTICE SENT TO IB